Actionnariat et activité des initiés pour Armata Pharmaceuticals, Inc. (ARMP): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.07 |
| Capitalisation | $149M |
| Bourse | AMEX |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.7M | $5.1M | $8.2M | $6.0M | $9.6M | $10.3M | $14.9M | $13.5M | $9.3M | $8.7M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $25000 | 0 | 0 | 0 | $561000 | $3.0M | $8.5M | $3.4M | $744000 | $472000 |
| Stocks | -$619000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $6.4M | $5.4M | $8.4M | $6.7M | $10.8M | $15.0M | $27.0M | $19.2M | $11.3M | $10.7M |
| Immobilisations Corporelles | $1.1M | $816000 | $503000 | $4.2M | $12.8M | $38.1M | $46.7M | $57.3M | $54.9M | $46.1M |
| Goodwill | 0 | 0 | 0 | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M |
| Actifs Incorporels | $10.8M | $4.9M | $3.0M | $10.3M | $10.3M | $10.3M | $10.3M | $10.3M | $10.3M | $10.3M |
| Actifs Totaux | $18.2M | $11.1M | $11.9M | $25.5M | $39.5M | $69.8M | $107.9M | $98.4M | $86.4M | $76.9M |
| Dettes Fournisseurs | $1.1M | $578000 | $729000 | $547000 | $956000 | $1.1M | $1.7M | $1.6M | $766000 | $921000 |
| Dette à Court Terme | $803000 | 0 | 0 | $1.3M | $722000 | 0 | 0 | 0 | $39.0M | 0 |
| Passifs Courants | $3.6M | $2.0M | $2.6M | $4.9M | $6.7M | $4.8M | $24.9M | $16.5M | $48.2M | $8.9M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $82.3M | $55.4M | $256.9M |
| Passifs Totaux | $8.5M | $3.4M | $3.4M | $10.9M | $20.7M | $44.4M | $71.8M | $130.4M | $134.5M | $295.5M |
| Réserves | -$381.4M | -$394.2M | -$406.3M | -$157.5M | -$179.7M | -$202.9M | -$239.8M | -$308.8M | -$327.7M | -$501.5M |
| Capitaux Propres | $9.7M | $7.7M | $8.5M | $14.6M | $18.9M | $25.4M | $36.1M | -$32.1M | -$48.0M | -$218.6M |
| Dette Totale | $803000 | 0 | 0 | $2.9M | $13.2M | $38.0M | $48.8M | $120.4M | $126.5M | $288.0M |
| Dette Nette | -$4.9M | -$5.1M | -$8.2M | -$3.2M | $3.5M | $27.7M | $34.0M | $106.8M | $117.2M | $279.3M |
| Fonds de Roulement | $2.8M | $3.4M | $5.8M | $1.8M | $4.1M | $10.2M | $2.2M | $2.7M | -$36.9M | $1.7M |
Santé financière
| Dette / Capitaux propres | -1.36 |
| Ratio de liquidité | 0.11 |
Rentabilité
| Rentabilité des capitaux propres | 89.70% |
| Rentabilité du capital investi | -47.40% |
| Rentabilité des actifs | -213.65% |
| Marge brute | 68.23% |
| Marge opérationnelle | -1233.59% |
| Marge nette | -5825.34% |
Entreprises liées: CCCC · CDXS · GNFT · IMDX · IPHA · NTHI · NVCT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ARMP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions